Page 444«..1020..443444445446..450460..»

Prometheus Biosciences Announces FDA Acceptance of IND Application for PRA023 and Commences Dosing in Phase 1a Clinical Study – BioSpace

Posted: Published on December 18th, 2020

SAN DIEGO, Dec. 15, 2020 /PRNewswire/ --Prometheus Biosciences, Inc. ("Prometheus"), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the diagnosis and treatment of inflammatory bowel disease (IBD), today announced FDA acceptance of its Investigational New Drug Application (IND) for PRA023 and that dosing has commenced in a Phase 1a clinical study in normal healthy volunteers. Continue reading

Posted in Ulcerative Colitis | Comments Off on Prometheus Biosciences Announces FDA Acceptance of IND Application for PRA023 and Commences Dosing in Phase 1a Clinical Study – BioSpace

Hofseth Biocare ASA: Last day of subscription period in the Subsequent Offering – GlobeNewswire

Posted: Published on December 18th, 2020

December 18, 2020 02:00 ET | Source: Hofseth Biocare ASA NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Reference is made to the stock exchange announcement by Hofseth BioCare ASA (the "Company") on 4 December 2020 regarding the approval by the Financial Supervisory Authority of Norway of the Company's prospectus dated 3 December 2020 (the "Prospectus") prepared in connection with inter alia, a subsequent offering of new shares in the Company (the "Offer Shares"). The subscription period in the Subsequent Offering will end today and Subscription Rights that are not used to subscribe for Offer Shares before 16:30 hours (CET) today, on 18 December 2020, will have no value and will lapse without compensation to the holder Continue reading

Posted in Ulcerative Colitis | Comments Off on Hofseth Biocare ASA: Last day of subscription period in the Subsequent Offering – GlobeNewswire

I Have a Chronic Illness. Here’s Why I Hate New Year’s Resolutions – Healthline

Posted: Published on December 18th, 2020

Written by Hattie Gladwell on December 15, 2020 Fact checked by Jennifer Chesak We need to stop starting every new year by setting these unreachable standards for ourselves. Each year, my social media feeds are filled with New Years resolutions. Continue reading

Posted in Ulcerative Colitis | Comments Off on I Have a Chronic Illness. Here’s Why I Hate New Year’s Resolutions – Healthline

Immunic, Inc. Added to NASDAQ Biotechnology Index – BioSpace

Posted: Published on December 18th, 2020

NEW YORK, Dec. Continue reading

Posted in Ulcerative Colitis | Comments Off on Immunic, Inc. Added to NASDAQ Biotechnology Index – BioSpace

Group of friends walk 10km to raise 1000 for Crohns and Colitis UK – Bridgwater Mercury

Posted: Published on December 18th, 2020

A GROUP of friends who all suffer from Crohns or Ulcerative Colitis took part in a 10km walk last month to raise funds for charity. Charlotte, Toni, Alice and Mike took on the challenge on October 25 with support from their family and friends. The team of four raised 1,085 for Crohns and Colitis UK - a charity which is dedicated to helping people with Crohn's disease, ulcerative colitis, and other forms of inflammatory bowel disease to live a better quality of life and ultimately find a cure. Continue reading

Posted in Ulcerative Colitis | Comments Off on Group of friends walk 10km to raise 1000 for Crohns and Colitis UK – Bridgwater Mercury

What is Stem Cell Research? – WorldAtlas

Posted: Published on December 18th, 2020

By Victor Kiprop on December 5 2018 in Did You Know A stem cell is a cell in a living body with the potential to develop into different types of cells during the early stage. Most cells in a living organism are differentiated cells, meaning they are found in a specific organ and perform particular functions. Continue reading

Posted in Stem Cell Research | Comments Off on What is Stem Cell Research? – WorldAtlas

stem cell | Definition, Types, Uses, Research, & Facts …

Posted: Published on December 18th, 2020

Stem cell, an undifferentiated cell that can divide to produce some offspring cells that continue as stem cells and some cells that are destined to differentiate (become specialized). Stem cells are an ongoing source of the differentiated cells that make up the tissues and organs of animals and plants. Continue reading

Posted in Stem Cell Research | Comments Off on stem cell | Definition, Types, Uses, Research, & Facts …

Stem cells: Therapy, controversy, and research

Posted: Published on December 18th, 2020

The idea of a miracle cure and bodies healing themselves holds a particular fascination. Continue reading

Posted in Stem Cell Research | Comments Off on Stem cells: Therapy, controversy, and research

At 14.6% CAGR, Cell Banking Outsourcing Market 2020 Industry Analysis of Current Trends and Opportun – PharmiWeb.com

Posted: Published on December 18th, 2020

Pune, Maharashtra, India, December 18 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd :Global Cell Banking Outsourcing Market is valued at USD 7122.6 Million in 2019 and expected to reach USD 18489.6 Million by 2026 with the CAGR of 14.6% over the forecast period. Rising prevalence of cancer and infectious chronic disorders couples with growing demand for research and development in therapy viral cell banking and viral cell banking safety testing are expected to propel the growth of the Global Cell Banking Outsourcing Market. Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/993 Scope of Global Cell Banking Outsourcing Market Report The cell banking outsourcing is an ability that stores cells of specific genome for the purpose of future use in a product or medicinal needs to use of gene therapy, stem cell therapy, biopharmaceutical production that target on novel active sites. Continue reading

Posted in Stem Cell Research | Comments Off on At 14.6% CAGR, Cell Banking Outsourcing Market 2020 Industry Analysis of Current Trends and Opportun – PharmiWeb.com

Glycostem and Ghent University sign license agreement on NK cell therapy technology | DNA RNA and Cells | News Channels – PipelineReview.com

Posted: Published on December 18th, 2020

Details Category: DNA RNA and Cells Published on Friday, 18 December 2020 13:05 Hits: 58 - New opportunities for the development of NK-antibody combination therapies - Significant positive effect on production time of Glycostem's lead product oNKord, and future CAR-NK and TCR-NK therapies OSS, The Netherlands I Dec. Continue reading

Posted in Stem Cell Research | Comments Off on Glycostem and Ghent University sign license agreement on NK cell therapy technology | DNA RNA and Cells | News Channels – PipelineReview.com

Page 444«..1020..443444445446..450460..»